Faecal microbiota transplantation (FMT) is used for recurrent Clostridium difficile infection (rCDI) as part of an quality improvement initiative and conducted within the framework of Center for Faecal Microbiota Transplantation at Aarhus University Hospital (CEFTA).
Patients are assessed, treated and monitored at Aarhus University Hospital (AUH) as an Integrated part of the project.
Study Type
OBSERVATIONAL
Enrollment
100
FMT delivered by colonoscopy, nasojejunal tube, glycerol-based capsules, or freeze-dried encapsulated donor faeces
Aarhus University Hospital
Aarhus N, Denmark
RECRUITINGResolution of Clostridium difficile-Associated disease (CDAD)
Number of patients with resolution of CDAD, , defined by the absense of diarrhea (3 or fewer bowel movements per day) and formed stools (Bristol 5 or lower) or, in the case of abnormal stool frequency or consistency, a negative Clostridium difficile toxin test week 8
Time frame: 8 weeks
Clinical effect week 8
Number of patients with clinical effect, defined by absense of diarrhea (3 or fewer bowel movements per day) and formed stools (Bristol 5 or lower)
Time frame: 8 weeks
Negative CD test week 8
Number of patients with negative Clostridium difficile toxin test week 8
Time frame: 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.